Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1982 Dec 1;156(6):1835–1841. doi: 10.1084/jem.156.6.1835

Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient

PMCID: PMC2186859  PMID: 6757374

Abstract

It has been previously shown that long surviving, enhanced (AS X AUG)F1 rat kidneys residing in a primary AS recipient are not acutely rejected if transferred into a second AS recipient. The reduced immunogenicity of the retransplanted graft was attributed to a depletion of incompatible passenger cells. It is shown here that if the primary AS recipient is made chimeric by x irradiation and injection of (AS X AUG)F1 bone marrow cells, transfer of the long surviving, enhanced graft into a second AS recipient provokes acute graft rejection comparable to that observed when normal (AS X AUG)F1 kidneys are transplanted into untreated AS recipients. Transplantation of passenger cell-depleted AUG kidneys into AS recipients leads to graft rejection, with a median survival time of 22 d. Treatment of these recipients with as little as 1.5 mg/kg cyclophosphamide for 14 d induces prolonged graft survival. By contrast, five times as much cyclophosphamide treatment is required to induce prolonged survival of normal AUG kidneys (i.e., containing incompatible passenger cells) transplanted to AS recipients. These results confirm that the major alloimmunogenic stimulus of rat kidney grafts is provided by the incompatible passenger cells.

Full Text

The Full Text of this article is available as a PDF (468.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Batchelor J. R., Welsh K. I., Maynard A., Burgos H. Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. J Exp Med. 1979 Sep 19;150(3):455–464. doi: 10.1084/jem.150.3.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fine R. N., Batchelor J. R., French M. E., Shumak K. H. The uptake of 125I-labeled rat alloantibody and its loss after combination with antigen. Transplantation. 1973 Dec;16(6):641–648. doi: 10.1097/00007890-197312000-00016. [DOI] [PubMed] [Google Scholar]
  3. Lechler R. I., Batchelor J. R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med. 1982 Jan 1;155(1):31–41. doi: 10.1084/jem.155.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Welsh K. I., Batchelor J. R., Maynard A., Burgos H. Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. II. Retransplantation of (AS X AUG)F1 kidneys from AS primary recipients into (AS X WF)F1 secondary hosts. J Exp Med. 1979 Sep 19;150(3):465–470. doi: 10.1084/jem.150.3.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Winearls C. G., Fabre J. W., Hart D. N., Millard P. R., Morris P. J. Passive enhancement and hyperacute rejection of renal allografts in the rat. Transplantation. 1980 Jun;29(6):462–467. doi: 10.1097/00007890-198006000-00007. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES